News
Hormone therapy has endured a rather bumpy history after the Women’s Health Initiative published clinical trial data in 2002 ...
A panel of 12 experts in the menopause field reexamined the findings of the 2002 Women’s Health Initiative study that said ...
Experts worry the warning on vaginal estrogen menopause treatments is doing more harm than good and is not supported by science.
JUUL GETS ITS CROWN — The FDA authorized Juul’s applications on Thursday to sell e-cigarettes in the U.S., determining ...
1d
Flow Space on MSNFDA Experts Call for Rethink on Menopause Hormone Therapy WarningsOn Thursday in Washington, D.C., the U.S. Food and Drug Administration (FDA) convened a panel of top experts to reassess the ...
Members of an FDA expert panel discussed reassessing boxed warnings for menopausal HT and how to better educate patients and ...
MENOPAUSAL THERAPY IN FOCUS — The FDA will hold a panel discussion Thursday on hormone therapy for menopausal women, a pet ...
Dr. Marty Makary, the agency’s commissioner, said too many women avoid hormone therapy because the risks have been overstated ...
1d
MedPage Today on MSNRemove Boxed Warning on Hormone Therapy for Menopause, FDA Panel SaysA panel selected by FDA Commissioner Marty Makary, MD, MPH, unanimously urged the agency to remove the boxed warning on ...
These symptoms could also be due to lowered testosterone levels. A 2023 study in the Journal of Clinical Endocrinology ...
An article in The Journal For Nurse Practitioners found that Depo-Testosterone was the most cost-efficient TRT option, and ...
While Astellas’ Veozah was the first neurokinin 3 (NK-3) receptor antagonist approved for menopause, Lynkuet is the first ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results